fda banning semaglutide bans compounded weight loss drugs this month Compounded "semaglutide" is not FDA-approved

Receptor-Binding Comparison Retatrutide and Weight Loss: What the Research Shows Phase 2 Body Weight Reduction Data (Jastreboff 2023) Phase 2 data on retatrutide weight loss first appeared in the New England Journal of Medicine in 2023

5B and Figure S5C)

Collagen occurs throughout the body, but especially in the skin, bones, and connective tissues

Key Points: GLP-1 agonists help regulate hormones indirectly by improving metabolic health

An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine

When retatrutide becomes commercially available, switching from Ozempic will likely be possible under medical supervision